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SYNTHESIS OF CYANINE 7
METHODOLOGY
v The Bossmann research group members
v Developing Scholars Program
v Bridges to the Future Program
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The objective of this project is to synthesize a fluorescent dye,
cyanine 7, as well as a protease peptide, to then link these two
to generate a fluorescent label peptide to be used for cancer
detection research.
ABSTRACT
All amino acids and resins (containing the first amino acid already linked) are
protected with an Fmoc group. The peptide synthesis cycle is as follows:
• Deprotection: cleavage of Fmoc using 20% dimethylamine.
• Washing: washings with DMF to remove excess cleaving solution.
• Coupling: carboxyl group of the next amino acid is activated and coupled to
the peptide chain using HBTU.
• The cycle of deprotection, washing and coupling is repeated until entire
sequence is completed.
• Last step: peptide can be labeled with a fluorescent dye, and then cleaved
from the resin using trifluoracetic acid.
CONCLUSION
v Successfully synthesized and characterized a blue
fluorescent dye, cyanine 7.
v Successfully learned the solid phase peptide synthesis,
and assisted on the synthesis of multiple protease and cell
penetrating peptides sequences.
v Cyanine 7 was characterized through NMR
and FTIR, by identifying major component
groups, like nitrogen, sulfur, and carboxyl
groups.
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v Continue exploring different mechanism pathways on how
to successfully attach cyanine 7 to a protease peptide in
order to be fluorescent.
v After peptide is successfully labeled, actual cleaving of
protease peptide substrate will be determined using an
active enzyme.
v Assemble a nanobiosensor composed of protease labeled
with cyanine 7 to quantify protease activity as a mean to
detect cancer.
Cancer occurs when a mutated single cell continues to divide
uncontrollably, developing into one of the 200 different cancer
types. Cancer is the second leading cause of death in the
United States, with approximately 1.7 million new cases
occurring this year [1]. Current cancer detection and
treatment techniques are costly and not optimal, due to the
lack of cancer specificity as well as early detection achieved
in some cancer types. This project focuses on the synthesis
development of peptides and fluorescent dyes that could be
used for cancer research. The solid phase peptide synthesis
procedure as well as cyanine 7 synthesis will be discussed
here. Cyanine 7 is a blue fluorescent dye synthesized and
used to label peptides, so they can be used to quantify
protease levels as an aim for cancer detection technique.
Establishing a well synthesized peptide will help us to
advance for better cancer detection and treatment
techniques.
Solid Phase Peptide Synthesis Procedure
Cancer
v As of 2019, about 606, 880 deaths will result from cancer in
the United States [1].
Current Cancer Detection Techniques
v MRI: images due to magnetic and radio waves.
• Drawbacks: causes nausea, pain at the needle site,
headaches, low blood pressure, and expensive [2].
v CT scan: shows tumor’s shape, size and location.
• Side effects: causes rash, nausea, shortness of breath,
itching or facial swelling. IV contrast dye could also affect
the kidneys [3].
Peptides Synthesized for Cancer Research
v Capable to penetrate cells while carrying and delivering
different payloads [4].
v Peptides with toxic properties can be synthesized to be
used as both the nanocarrier and the anticancer drug.
v The Bossmann group have developed peptide-based
nanobiosensors for early detection of pancreatic cancer [5].
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